Structural Heart Imaging Market Size & Share, By Modality (Echocardiogram, Angiogram), Procedure (TAVR, SAVR, TMVR, LAAC), Application, End-use - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Market Outlook:

Structural Heart Imaging Market size is set to increase from USD 9.24 billion in 2024 to USD 16.24 billion by 2034, with a projected CAGR exceeding 5.8% from 2025 to 2034. The industry revenue for 2025 is anticipated to hit USD 9.73 billion.

• Base Year Value (2024): USD 9.24 billion
• CAGR (2025-2034): 5.8%
• Forecast Year Value (2034): USD 16.24 billion
• Historical Data Period: 2021-2034
• Largest Region: Europe
• Forecast Period: 2025-2034

Market Dynamics:

Growth Drivers & Opportunities

The Structural Heart Imaging Market is experiencing robust growth driven primarily by advancements in imaging technologies. Innovations such as 3D echocardiography, cardiac MRI, and CT imaging have significantly enhanced diagnostic accuracy for heart diseases, allowing for earlier interventions. These technologies not only improve imaging quality but also offer non-invasive options, which are highly appealing to both patients and healthcare professionals.

Increasing prevalence of cardiovascular diseases globally has created a heightened demand for effective diagnostic and treatment solutions. This has accelerated research and development efforts within the field, leading to the introduction of new imaging modalities that provide detailed anatomical views and functional assessments of the heart, thereby expanding the potential market reach.

Additionally, the aging population is another critical factor propelling market growth. As individuals age, the risk of heart-related ailments escalates, necessitating frequent cardiac evaluations and interventions. This demographic trend emphasizes the need for advanced imaging solutions to adequately assess and manage heart health.

Moreover, expanding healthcare infrastructure in emerging markets presents a vast opportunity for the Structural Heart Imaging Market. As these regions invest in better healthcare facilities and access to advanced medical technologies, there is a growing demand for innovative imaging solutions that can support better cardiovascular care.

Report Scope

Report Coverage	Details
Segments Covered	Modality, Procedure, Application, End Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems, Fujifilm Holdings, Shanghai United Imaging Healthcare Co., LTD, Abbott, Terumo, Samsung Medison, Lepu Medical Technology

Industry Restraints:

Despite the promising growth potential, the Structural Heart Imaging Market faces several

Report Scope

Report Coverage	Details
Segments Covered	Modality, Procedure, Application, End Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems, Fujifilm Holdings, Shanghai United Imaging Healthcare Co., LTD, Abbott, Terumo, Samsung Medison, Lepu Medical Technology

Industry Restraints: that could hinder its expansion. The high cost associated with advanced imaging technologies poses a significant barrier to adoption, particularly in low- and middle-income countries. Limited financial resources in these regions can restrict access to the latest equipment and technologies, which may lead to disparities in healthcare quality.

Additionally, regulatory challenges can impede the swift integration of new imaging modalities into clinical practice. Compliance with stringent regulations for medical devices and diagnostic tools often prolongs the approval process, delaying market entry for innovative solutions. Healthcare providers may also demonstrate hesitance in adopting newer technologies due to concerns around training and implementation costs.

Furthermore, a lack of skilled professionals capable of operating advanced imaging machinery presents another challenge. The requirement for specialized training to operate these technologies limits the number of practitioners, consequently affecting service delivery in a timely manner.

Lastly, the ongoing impact of economic fluctuations and healthcare budget constraints can lead to reduced funding for cardiac imaging projects, which could inhibit market growth and innovation. As healthcare systems prioritize spending, structural heart imaging may struggle to secure necessary resources compared to other urgent healthcare needs.

Regional Forecast:

North America

The North American structural heart imaging market is predominantly led by the United States, driven by advancements in medical technology and substantial healthcare investments. The U.S. is characterized by a high prevalence of cardiovascular diseases, prompting increased demand for early and accurate diagnostics. The presence of major players in the medical imaging sector has further stimulated market growth. Canada is also witnessing significant advancements in healthcare, though it may not achieve the same market size as the U.S. Overall, this region is expected to maintain a dominant position, supported by ongoing research and innovation in structural heart imaging techniques.

Asia Pacific

In the Asia Pacific region, countries like China and Japan are poised for significant growth in the structural heart imaging market. China, with its massive population and increasing healthcare expenditure, is rapidly adopting advanced imaging technologies to address the rising incidence of cardiovascular ailments. Japan, known for its technological advancements, is also enhancing its market through the integration of AI and digital health solutions in imaging. South Korea, with a robust healthcare system and high investment in health tech, is expected to contribute positively to market dynamics. This region is projected to be among the fastest-growing markets due to improved healthcare access and rising awareness.

Europe

The European structural heart imaging market showcases strong potential, particularly in Germany, the United Kingdom, and France. Germany stands out due to its advanced healthcare infrastructure and favorable regulatory environment, fostering innovation in medical imaging technologies. The UK, with its extensive research and development ecosystem for medical devices and imaging solutions, is also positioned for healthy market growth. France is leveraging its strong healthcare framework and growing emphasis on cardiovascular health, making it a key player in the region. As Europe focuses on improving healthcare outcomes, the structural heart imaging market is expected to flourish in these countries, facilitated by collaborative efforts between healthcare professionals and technology providers.

Segmentation Analysis:

In terms of segmentation, the global Structural Heart Imaging market is analyzed on the basis of Modality, Procedure, Application, End Use.

Modality

The Structural Heart Imaging Market is primarily segmented by modality, which includes ultrasound, MRI, CT scans, and X-ray imaging. Among these, ultrasound is likely to exhibit the largest market size due to its widespread application, real-time imaging capabilities, and cost-effectiveness. Close behind, MRI is expected to grow rapidly as its advanced imaging techniques enhance visualization of complex cardiac structures, making it indispensable for accurate assessments. CT scans, while currently smaller in market size, are set to see significant growth due to advancements in imaging technology and radiological methods that allow for detailed cardiovascular evaluations.

Procedure

The procedural segmentation encompasses transcatheter interventions, open-heart surgeries, and minimally invasive procedures. Transcatheter interventions are anticipated to dominate the market, driven by an increase in procedures such as transcatheter aortic valve replacement (TAVR) and MitraClip implantation. The preference for minimally invasive procedures is on the rise, fostering rapid growth in this segment, as they offer reduced recovery times and lower complication rates. Open-heart surgeries, while still crucial for certain patient populations, are likely to experience slower growth due to the shift towards less invasive techniques.

Application

Within the application segment, diagnostic imaging, treatment planning, and post-procedural monitoring hold significant relevance. The diagnostic imaging application is expected to command the largest market share, as accurate diagnosis is foundational for effective treatment of structural heart diseases. Treatment planning is also projected to grow swiftly, facilitated by enhanced imaging technologies that allow for better pre-surgical analysis and strategy formulation. Post-procedural monitoring applications are gaining traction as healthcare providers focus on optimizing patient outcomes through continuous assessment and image review after interventions.

End Use

The end-use category includes hospitals, diagnostic imaging centers, and research centers. Hospitals are expected to maintain the largest market share due to their extensive capabilities in providing comprehensive care and advanced imaging solutions. However, diagnostic imaging centers are likely to exhibit the fastest growth, spurred by an increase in outpatient services and a growing preference for specialized imaging solutions. Research centers, while smaller in market size, are pivotal for innovation and development in imaging technologies, contributing significantly to the market’s future advancements.

Competitive Landscape:

The competitive landscape in the Structural Heart Imaging Market is characterized by a mix of established medical device manufacturers and innovative startups focusing on advanced imaging technologies and solutions. Key players are investing heavily in research and development to enhance the accuracy and efficiency of imaging techniques such as echocardiography, MRI, and CT scans for structural heart disease assessment. Additionally, collaborations and partnerships between technology companies and healthcare providers are becoming increasingly common to improve diagnostic capabilities and patient outcomes. The market is witnessing rapid advancements in artificial intelligence and machine learning applications, allowing for better analysis of imaging data and personalized treatment plans. As competition intensifies, companies are also focusing on regulatory compliance and market penetration strategies to capture a larger share in this growing market.

Top Market Players

1 Siemens Healthineers

2 GE Healthcare

3 Philips Healthcare

4 Canon Medical Systems

5 Abbott Laboratories

6 Medtronic

7 Johnson & Johnson

8 Boston Scientific

9 Edwards Lifesciences

10 Terumo Corporation